Dr Lal Pathlabs
Diagnostics & Research · LALPATHLAB
Mid CapHealthcareMature Stable
Dr. Om Prakash Manchanda
Managing Director · Transformational
Company DNA
Performance-Driven
About
Dr Lal Pathlabs is a Mid Cap company in the Healthcare sector, listed on NSE as LALPATHLAB. With a market cap of ₹23K Cr and revenue of ₹2K Cr, it is currently in the Mature Stable phase. Known for its Performance-Driven culture and Fast-Follower approach to innovation, the company operates at a Steady-Marathon pace. High focus on scale, diagnostic efficiency, and aggressive growth, balancing medical rigour with modern corporate sales performance targets. Its strategic mandate: To maintain market leadership amidst intense competition, the focus must shift to maximizing service reliability and customer experience.
FAQ
What kind of company is Dr Lal Pathlabs?
Dr Lal Pathlabs is a Mid Cap Healthcare company (LALPATHLAB) in the Mature Stable phase with a market cap of ₹23K Cr. It is classified as Performance-Driven in culture.
What is Dr Lal Pathlabs's culture and work environment like?
Dr Lal Pathlabs has a Performance-Driven culture with Fast-Follower innovation DNA and a Steady-Marathon pace of execution. Employee brand: Steady Employer. Customer relationship style: Mass-Consumer. High focus on scale, diagnostic efficiency, and aggressive growth, balancing medical rigour with modern corporate sales performance targets.
Who leads Dr Lal Pathlabs?
Dr Lal Pathlabs is led by Dr. Om Prakash Manchanda (Managing Director), a Transformational leader with 35 years of experience.
What are Dr Lal Pathlabs's financials?
Dr Lal Pathlabs reported revenue of ₹2K Cr in FY25 with a 5-year revenue CAGR of 5.6%. Operating margin: 22.8%. Market cap: ₹23K Cr.
Culture & Strategy
CulturePerformance-Driven
InnovationFast-Follower
PaceSteady-Marathon
PurposePurpose-Blended
CustomerMass-Consumer
EmployeeSteady Employer
BrandTrusted
LifecycleMature Stable
High focus on scale, diagnostic efficiency, and aggressive growth, balancing medical rigour with modern corporate sales performance targets.
Mandate
To maintain market leadership amidst intense competition, the focus must shift to maximizing service reliability and customer experience.
To maintain market leadership amidst intense competition, the focus must shift to maximizing service reliability and customer experience.
Financials
Revenue FY25₹2K Cr
PAT FY25₹487 Cr
Rev CAGR 5Y5.6%
OPM22.8%
NPM19.8%
ROE22.4%
ROCE24.2%
P/E42.9
Fwd P/E38.3
P/B9.5
D/E6.4
Mkt Cap₹23K Cr
Promoter56%
Institutional33.3%
Similar Culture
Could You Lead Dr Lal Pathlabs?
Take the Genome Benchmark →